-
Loading metrics
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
- Jennifer M. Atkinson,
- Kenneth B. Rank,
- Yi Zeng,
- Andrew Capen,
- Vipin Yadav,
- Jason R. Manro,
- Thomas A. Engler,
- Marcio Chedid
x
- Published: April 27, 2015
- https://doi.org/10.1371/journal.pone.0125028